UV Spectophotometric Method Development & Validation in Bulk Drugs and In Tablet Dosage Form of Sitagliptin by Using Methnol, Water & Acetnitrile as Solvents

This research focused on the development and validation of innovative UV spectrophotometric techniques for the quantification of sitagliptinin pharmaceutical formulations, adhering to ICH Q2 (R1) guidelines. The zero-order derivative spectrophotometric approach proved to be cost-effective and reproducible for both active pharmaceutical ingredients. Key validation parameters, such as accuracy, precision, specificity, and linearity, were rigorously assessed and confirmed compliance with both ICH and USP standards. The methods demonstrated simplicity, reliability, and precision, making them well-suited for routine analytical procedures with high accuracy. The precision of the methods, assessed via repeatability, was validated by analyzing multiple aliquots from homogeneous samples, yielding satisfactory results. When applied to sitagliptin tablet formulations, the methods showed no interference from excipients, highlighting their practical utility in pharmaceutical analysis. Compared to existing techniques, these methods offer significant advantages in terms of sensitivity, simplicity, and cost-efficiency. Moreover, they require only basic instrumentation, which reduces the need for complex procedural steps, additional reagents, or lengthy analysis times. The developed methods' affordability and minimal maintenance requirements make them highly suitable for use in small-scale pharmaceutical industries, ensuring consistent therapeutic efficacy in drug formulations. The primary focus of this study was on optimizing the methods to improve their performance, ensuring that the final methods could be quickly validated and efficiently applied to the analysis of both preclinical and commercial samples. Through a review of the current literature on the analysis of sitagliptin, it was evident that there was a gap in the availability of validated methods for their analysis in bulk and pharmaceutical dosage forms. This study addresses that gap by offering refined UV spectrophotometric methods that meet the required standards for quantitative analysis, demonstrating specificity, linearity, accuracy, and precision. These methods are fully aligned with regulatory requirements, making them ideal for routine use in pharmaceutical quality control.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-02-23
DOI
https://doi.org/10.5281/zenodo.14913287
Primary Topic
Mediterranean and Iberian flora and fauna
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

UV Spectophotometric Method Development & Validation in Bulk Drugs and In Tablet Dosage Form of Sitagliptin by Using Methnol, Water & Acetnitrile as Solvents

Zenodo (CERN European Organization for Nuclear Research)
Mediterranean and Iberian flora and fauna
article

UV Spectophotometric Method Development & Validation in Bulk Drugs and In Tablet Dosage Form of Sitagliptin by Using Methnol, Water & Acetnitrile as Solvents

article en

Abstract

This research focused on the development and validation of innovative UV spectrophotometric techniques for the quantification of sitagliptinin pharmaceutical formulations, adhering to ICH Q2 (R1) guidelines. The zero-order derivative spectrophotometric approach proved to be cost-effective and reproducible for both active pharmaceutical ingredients. Key validation parameters, such as accuracy, precision, specificity, and linearity, were rigorously assessed and confirmed compliance with both ICH and USP standards. The methods demonstrated simplicity, reliability, and precision, making them well-suited for routine analytical procedures with high accuracy. The precision of the methods, assessed via repeatability, was validated by analyzing multiple aliquots from homogeneous samples, yielding satisfactory results. When applied to sitagliptin tablet formulations, the methods showed no interference from excipients, highlighting their practical utility in pharmaceutical analysis. Compared to existing techniques, these methods offer significant advantages in terms of sensitivity, simplicity, and cost-efficiency. Moreover, they require only basic instrumentation, which reduces the need for complex procedural steps, additional reagents, or lengthy analysis times. The developed methods' affordability and minimal maintenance requirements make them highly suitable for use in small-scale pharmaceutical industries, ensuring consistent therapeutic efficacy in drug formulations. The primary focus of this study was on optimizing the methods to improve their performance, ensuring that the final methods could be quickly validated and efficiently applied to the analysis of both preclinical and commercial samples. Through a review of the current literature on the analysis of sitagliptin, it was evident that there was a gap in the availability of validated methods for their analysis in bulk and pharmaceutical dosage forms. This study addresses that gap by offering refined UV spectrophotometric methods that meet the required standards for quantitative analysis, demonstrating specificity, linearity, accuracy, and precision. These methods are fully aligned with regulatory requirements, making them ideal for routine use in pharmaceutical quality control.

Zenodo (CERN European Organization for Nuclear Research)
Industry, innovation and infrastructure
Openalex Percentile: Top 44%
Mediterranean and Iberian flora and fauna
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.